CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $408,000 | -9.9% | 165,330 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $453,000 | +77.6% | 165,330 | 0.0% | 0.02% | +60.0% |
| Q3 2020 | $255,000 | -18.0% | 165,330 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $311,000 | +10.7% | 165,330 | 0.0% | 0.01% | -7.7% |
| Q1 2020 | $281,000 | -41.3% | 165,330 | 0.0% | 0.01% | -27.8% |
| Q4 2019 | $479,000 | +360.6% | 165,330 | 0.0% | 0.02% | +260.0% |
| Q3 2019 | $104,000 | -35.4% | 165,330 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $161,000 | -29.4% | 165,330 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $228,000 | +28.8% | 165,330 | 0.0% | 0.01% | +12.5% |
| Q4 2018 | $177,000 | -65.2% | 165,330 | +100.0% | 0.01% | -55.6% |
| Q3 2018 | $508,000 | -42.5% | 82,665 | 0.0% | 0.02% | -47.1% |
| Q2 2018 | $884,000 | – | 82,665 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |